Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Equity (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Return on Equity over the past 15 years, most recently at 0.0% for Q1 2025.

  • For Q1 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM value through Feb 2025 reached 0.0%, changed 0.0%, while the annual FY2024 figure was 0.01%, 2.0% up from the prior year.
  • Return on Equity for Q1 2025 was 0.0% at Lifecore Biomedical, Inc. \De\, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.04% in Q4 2023 and troughed at 0.02% in Q2 2023.
  • A 5-year average of 0.0% and a median of 0.0% in 2021 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: grew 5bps in 2023 and later fell -4bps in 2024.
  • Year by year, Return on Equity stood at 0.0% in 2021, then plummeted by -208bps to 0.01% in 2022, then soared by 576bps to 0.04% in 2023, then crashed by -97bps to 0.0% in 2024, then tumbled by -100bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for LFCR at 0.0% in Q1 2025, 0.0% in Q4 2024, and 0.0% in Q3 2024.